相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LINC00649 Facilitates the Cellular Process of Bladder Cancer Cells via Signaling Axis miR-16-5p/JARID2
Yongsong Liu et al.
UROLOGIA INTERNATIONALIS (2022)
Identification of dysregulated pathways underlying HTLV-1-associated myelopathy/tropical spastic paraparesis through co-expression network analysis
Mohadeseh Zarei Ghobadi et al.
JOURNAL OF NEUROVIROLOGY (2021)
Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts
Sharon L. Freshour et al.
NUCLEIC ACIDS RESEARCH (2021)
MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer (vol 9, 114, 2017)
Alejandra Sandoval-Borquez et al.
CLINICAL EPIGENETICS (2021)
MiR-20a-5p Negatively Regulates NR4A3 to Promote Metastasis in Bladder Cancer
Haibei Yang et al.
Journal of Oncology (2021)
The potential role of miR-124-3p in tumorigenesis and other related diseases
Qian Li et al.
MOLECULAR BIOLOGY REPORTS (2021)
Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism
Mohamed Elbadawy et al.
CANCER BIOLOGY & THERAPY (2021)
An immune cell infiltration-related gene signature predicts prognosis for bladder cancer
Hualin Chen et al.
SCIENTIFIC REPORTS (2021)
LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p
Xiancheng Han et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
Cora Palanca-Ballester et al.
CANCERS (2021)
Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer
Runzhi Huang et al.
BIOENGINEERED (2021)
Screening key miRNAs and genes in prostate cancer by microarray analysis
Jianhui Wu et al.
TRANSLATIONAL CANCER RESEARCH (2020)
A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
Chunmei Guo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis
Natalia I. Diaz-Valdivia et al.
ONCOGENE (2020)
A Weighted Gene Co-expression Network Analysis Reveals lncRNA Abnormalities in the Peripheral Blood Associated With Ultra-High-Risk for Psychosis
Yan Ren et al.
FRONTIERS IN PSYCHIATRY (2020)
Expression profile of microRNAs in bladder cancer and their application as biomarkers
Mohammad Taheri et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
MicroRNA Dysregulation and Non-Muscle-Invasive Bladder Cancer Prognosis
Angeline S. Andrew et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 Expression as Biomarker for Prostate Cancer Diagnosis
Leire Moya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Bladder cancer stage-associated hub genes revealed by WGCNA co-expression network analysis
Yu Di et al.
HEREDITAS (2019)
microRNA-16-5p-containing exosomes derived from bone marrow-derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2
Yan Xu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma
Zhikui Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma
Xiaonan Xi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
Yuki Kita et al.
BRITISH JOURNAL OF CANCER (2019)
MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer
Jin-Rong Wang et al.
CANCER BIOMARKERS (2019)
miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis
Yuemei Yang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Up-regulated expression of miR-155 in human colonic cancer
Hongliang Cao et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
TAM 2.0: tool for MicroRNA set analysis
Jianwei Li et al.
NUCLEIC ACIDS RESEARCH (2018)
Prostaglandin-endoperoxide synthase 2 (cyclooxygenase-2), a complex target for colorectal cancer prevention and therapy
Roberto Benelli et al.
TRANSLATIONAL RESEARCH (2018)
SIK1-LNC represses the proliferative, migrative, and invasive abilities of lung cancer cells
Liu Yang et al.
ONCOTARGETS AND THERAPY (2018)
miR-16-5p inhibits chordoma cell proliferation, invasion and metastasis by targeting
Hongliang Zhang et al.
CELL DEATH & DISEASE (2018)
MiR-192-5p suppresses the growth of bladder cancer cells via targeting Yin Yang 1
Decai Ji et al.
HUMAN CELL (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy
Tracy L. Rose et al.
BRITISH JOURNAL OF CANCER (2018)
miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD
Guoqiang Yu et al.
ONCOLOGY REPORTS (2017)
Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis
Da-nian Dai et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor
Yan-Ni Liang et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Urinary cell microRNA-based prognostic classifier for nonmuscle invasive bladder cancer
Mercedes Ingelmo-Torres et al.
ONCOTARGET (2017)
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation
Angela M. Halstead et al.
ELIFE (2017)
Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy
Elnaz Pashaei et al.
PLOS ONE (2017)
Characterization of transcriptional modules related to fibrosing-NAFLD progression
Yi Lou et al.
SCIENTIFIC REPORTS (2017)
Ritonavir and ixazomib kill bladder cancer cells by causing ubiquitinated protein accumulation
Akinori Sato et al.
CANCER SCIENCE (2017)
Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer
K. Miyamoto et al.
BRITISH JOURNAL OF CANCER (2016)
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity
Noah M. Hahn et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2
Jingyu Liu et al.
ONCOTARGETS AND THERAPY (2016)
Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer
Haiyang Zhang et al.
PROTEIN & CELL (2016)
The role of MicroRNAs in human cancer
Yong Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy
Bentao Shi et al.
BMC CANCER (2015)
Cancer biomarker detection: recent achievements and challenges
Li Wu et al.
CHEMICAL SOCIETY REVIEWS (2015)
MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer
David A. Armstrong et al.
MOLECULAR CANCER (2015)
miRWalk2.0: a comprehensive atlas of microRNA-target interactions
Harsh Dweep et al.
NATURE METHODS (2015)
MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression
Sung Lyea Park et al.
ONCOLOGY REPORTS (2015)
Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer
R. Vishnubalaji et al.
CELL DEATH & DISEASE (2015)
The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma
Rui Liu et al.
ONCOTARGET (2015)
Let-7b-5p regulates proliferation and apoptosis in multiple myeloma by targeting IGF1R
Honghai Xu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2014)
MicroRNA-124 Controls the Proliferative, Migratory, and Inflammatory Phenotype of Pulmonary Vascular Fibroblasts
Daren Wang et al.
CIRCULATION RESEARCH (2014)
Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer
Xuanjun Zhou et al.
MEDICAL ONCOLOGY (2014)
miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6
Fei Li et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2014)
Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells
M. Santoni et al.
BRITISH JOURNAL OF CANCER (2013)
MicroRNA-124 Suppresses the Transactivation of Nuclear Factor of Activated T Cells by Targeting Multiple Genes and Inhibits the Proliferation of Pulmonary Artery Smooth Muscle Cells
Kang Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety
A. Z. Badros et al.
LEUKEMIA (2013)
MiR-24 Promotes the Survival of Hematopoietic Cells
Tan Nguyen et al.
PLOS ONE (2013)
Plasma microRNA profiles for bladder cancer detection
Liana Adam et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)
Boris Cvek
DRUG DISCOVERY TODAY (2012)
Importin-α1 as a Novel Prognostic Target for Hepatocellular Carcinoma
Kenichiro Yoshitake et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome
Chun-I. Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3
Li Huang et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Pazopanib Synergizes with Docetaxel in the Treatment of Bladder Cancer Cells
Yuan Li et al.
UROLOGY (2011)
Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib
Paul W. Manley et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Stimulatory effects of the multi-kinase inhibitor sorafenib on human bladder cancer cells
A. Rose et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy
Lawrence R. Dick et al.
DRUG DISCOVERY TODAY (2010)
Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer
Saskia M. Wilting et al.
MOLECULAR CANCER (2010)
Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia
Xabier Agirre et al.
CANCER RESEARCH (2009)
The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation
Pauline J. Van der Watt et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207
J. E. Rosenberg et al.
ANNALS OF ONCOLOGY (2008)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
Forced COX-2 expression induces PGE2 and invasion in immortalized urothelial cells
Jason Gee et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest
Wan Seok Yang et al.
GENOME BIOLOGY (2008)
Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification
C. D. Hurst et al.
ONCOGENE (2008)
Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R
Peter Langfelder et al.
BIOINFORMATICS (2008)
Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study
Olivier Rixe et al.
LANCET ONCOLOGY (2007)
E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer
M. Oeggerli et al.
ONCOGENE (2006)
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Michael R. Mancuso et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Gene expression profiling of primary cutaneous melanoma and clinical outcome
VR Winnepenninckx et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Epithelial growth factor-induced phosphorylation of caveolin 1 at tyrosine 14 stimulates caveolae formation in epithelial cells
L Orlichenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Amplification and overexpression of E2F3 in human bladder cancer
A Feber et al.
ONCOGENE (2004)
E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer
M Oeggerli et al.
ONCOGENE (2004)
Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data
C Pilarsky et al.
NEOPLASIA (2004)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types
J Baselga et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
The way things move: Looking under the hood of molecular motor proteins
RD Vale et al.
SCIENCE (2000)
分享论文
